Markets:

Overview

News

Currencies

International

Treasuries

Clearmind Medicine Inc. - Common Shares (NQ:CMND)

0.8200 -0.0443 (-5.13%)

Streaming Delayed Price Updated: 10:54 AM EDT, Sep 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Clearmind Medicine Inc. - Common Shares

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Clearmind Medicine Inc. Is Disrupting The Pharmaceuticals Landscape; First-To-Market Psychedelic-Based Treatment For AUD In Its Crosshairs ($CMND)

December 21, 2022

Via AB Newswire

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More ↗

December 19, 2022

Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed.

Via Benzinga

Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment ↗

December 19, 2022

Psychedelics company Clearmind Medicine Inc. (NASDAQ: CMND) aims to bring its proprietary compound, CMND-100, to clinical trials while developing additional proprietary psychedelic compounds for...

Via Benzinga

Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session ↗

December 15, 2022

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.

Via Benzinga

Israeli Based Biotech Company Clearmind Medicine Inc’s CEO, Dr. Adi Zuloff-Shani, Issues Letter to Shareholders

December 15, 2022

From Clearmind Medicine Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 15, 2022

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100

December 13, 2022

From Clearmind Medicine Inc.

Via GlobeNewswire

Israeli Biotech Clearmind Medicine Appoints ex-Red Bull Executive Special Advisor for Developing MEAI as Alcohol Substitute

December 09, 2022

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More ↗

November 29, 2022

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon

Via Benzinga

Clearmind Gears Up For Clinical Trial To Test Drug That Treats Alcohol Addiction ↗

November 23, 2022

Israeli psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) is commencing the production of its proprietary drug candidate based on the MEAI molecule.

Via Benzinga

Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial

November 23, 2022

From Clearmind Medicine Inc.

Via GlobeNewswire

Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More ↗

November 21, 2022

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

Via Benzinga

Aegis Capital Corp. Acted as Sole Bookrunner on a $7.5 Million Underwritten Public Offering & Uplisting for Clearmind Medicine Inc. (NASDAQ: CMND)

November 17, 2022

Via ACCESSWIRE

Clearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market

November 17, 2022

From Clearmind Medicine Inc.

Via GlobeNewswire

This Psychedelics Company Begins Trading On NASDAQ With $7.5M Offering Then Reverse Stock Split ↗

November 15, 2022

Psychedelics biotech firm Clearmind Medicine Inc.

Via Benzinga

Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected ↗

November 15, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Tuesday.

Via Benzinga

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.